Another DSO Open MIC session is in the books! Thank you for attending today's afternoon session. These sessions are a space for open exchanges about ongoing topics around DSO and an opportunity to share, ask questions, provide feedback, or just listen. Everyone is invited to attend, participation is voluntary, and the sessions will not be recorded. Bayer terms & conditions apply: https://www.bayer.com/poap-tc

Felix Hoffmann, a chemist at the German pharmaceutical company Bayer, synthesized acetylsalicylic acid in a pure and stable form in 1897. Bayer patented the drug on March 6, 1899 under the name "Aspirin," issued in the US as patent 644,077, on 27 February 1900. It quickly became the world's most widely used medication (and it is today as of 2017). Aspirin was touted for its pain-relieving, anti-inflammatory, and antipyretic (fever-reducing) properties. It was indicated for a variety of conditions, including headache, dental pain, menstrual cramps, muscle and joint aches, and fever. Aspirin started as powder, but soon enough was pressed into tablets with the iconic Bayer logo. In the 1970s, studies began to reveal its potential in preventing heart attacks, leading to its use in low doses for cardiovascular protection. In 1982, Sir John Vane won a Nobel Prize for discovering aspirin's action in inhibiting prostaglandin synthesis. Today, Aspirin is on the World Health Organization's List of Essential Medicines, highlighting its importance in global health. It's estimated that annually, over 60 billion Aspirin tablets (35,000+ tons) are consumed worldwide, and a trillion since 100 years, underscoring its enduring impact on medicine. Its adoption for cardiovascular disease prevention and its role in pain and fever management make it a cornerstone of modern therapy. More: https://en.wikipedia.org/wiki/History_of_aspirin Art&Text🫶ChatGPT.

"Reinventing Organizations" is a book by Frederic Laloux that delves into the evolution of human consciousness and how it has shaped organizational structures through history. Organizations span a range from impulsive (red) to pluralistic (green), and a new, evolutionary level called "teal" introduced. Laloux researched 50+ organizations he considers in the teal stage and describes their management practices. Teal organizations' principles are self-management, wholeness, and evolutionary purpose. Self-management removes traditional hierarchies in favor of decentralized decision-making. Wholeness encourages employees to bring their full selves to work, rather than a professional persona. Evolutionary purpose means the organization adapts and grows, driven by its own inherent direction, not a fixed goal. Laloux's inspiration can be traced back to earlier management thinkers and human development psychologists, such as Ken Wilber's Integral Theory, along with the developmental models of Clare W. Graves and the subsequent Spiral Dynamics of Don Beck and Chris Cowan. They have been criticized, lack mainstream academic support, and compared to a cult. The book has inspired business leaders to rethink traditional management practices and explore more holistic, adaptive, empowering ways to organize work, and influenced small startups to large corporations to adopt more conscious practices. https://en.wikipedia.org/wiki/Reinventing_Organizations Art&Text🫶ChatGPT.

Thank you for participating at today's townhall! Q&A, sharing project updates, and providing insights & perspectives about our plans moving forward - everybody had their fair share of inspiration (and hopefully laughter as well! :) Bayer terms & conditions: https://www.bayer.com/en/poap-tc Art by nightcafe

I was present at the opening of Strategy & Architecture Open Space Session with Patrick 20 June 2023

I visited the Byron Bar at the Bayer Pharmaceuticals Headquarters in Berlin during the spring of 2023. Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2022, the Group employed around 101,000 people and had sales of 50.7 billion euros. R&D expenses before special items amounted to 6.2 billion euros. For more information, go to www.bayer.com. Find more information at https://pharma.bayer.com. Facebook: http://www.facebook.com/bayer. Twitter: @BayerPharma. Art by POAP Studio, https://www.poap.studio/. Bayer POAPs terms and conditions: https://bayer.com/poap.

During this meeting, we will talk about License Demand Management, our Radiology IT Platform Strategy, the current Solution Design Process, and other topics like new Innovation tools and the upcoming Deep Racer event. Art by Stable Diffusion.